This trial uses a smartphone app to help prevent readmissions after major cancer surgery, improving outcomes, reducing mortality, and saving costs.
- Bladder Cancer
- Radical Cystectomy
5 Primary · 3 Secondary · Reporting Duration: 42 days post hospital discharge
Awards & Highlights
1 Treatment Group
1 of 1
250 Total Participants · 1 Treatment Group
Primary Treatment: CLEAR CC · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there opportunities for newly enrolled participants to join this trial?
"Indeed, clinicaltrials.gov indicates that this medical experiment has been opened and is now recruiting participants since December 1st 2022. The last update to the study was November 8th 2022, with an aim of enrolling 250 patients at a single location." - Anonymous Online Contributor
To what extent is this trial populated with participants?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, which was first made public on December 1st 2022, is currently recruiting participants for the study. 250 participants are required to join from a single medical centre." - Anonymous Online Contributor